Interesting IBM Put And Call Options For February 2026

StockOptionsChannel highlights two IBM option ideas around the $299.41 share price: selling the $295 put (bid $9.65) would obligate purchase at $295 and nets a cost basis of $285.35, with a 58% chance to expire worthless and a 3.27% return (27.14% annualized) on cash at risk; selling a $305 call as a covered call (bid $10.30) would cap sale at $305 and yields a 5.31% total return if called at Feb 2026, with a 53% chance to expire worthless and a 3.44% premium boost (28.54% annualized). Implied vols are ~33% (put) and 34% (call) versus a trailing 12-month volatility of 30%.

Analysis

Market structure: The current option flow (Feb‑2026 $295 put bid $9.65, $305 call bid $10.30) favors income-seeking option sellers — institutional cash‑secured put writers and covered‑call retail/SMID desks capture immediate yield (3.3%–3.4% nominal, ~27–29% annualized) while risking assignment or capped upside. Winners are options desks and yield‑hungry allocators; losers are momentum/long‑only holders who would be forced to sell into assignment or miss large upside above $305. The modest IV premium (33–34% vs realized 30%) signals limited tail‑risk pricing rather than a crisis-implied bid.

Risk assessment: Short‑tail risk is assignment over the next weeks around quarterly earnings or headline AI contract wins; medium term (months) the key risk is a macro tech spend pullback compressing TTM revenue and raising loss probability beyond the 42% current OTM put hit‑rate. Tail scenarios include a large client churn/contract loss or a deeper recession pushing IBM below $250 (20% downside), which would render premium income trivial versus capital loss. Hidden dependency: selling puts implicitly leverages balance‑sheet views — assignment converts option premium into concentrated equity exposure at $285.35.

Trade implications: Direct actionable plays — (A) sell cash‑secured Feb‑2026 $295 puts size 1–3% NAV if willing to own IBM at $285.35; set max simulated drawdown = 12% (close/roll if IBM < $270). (B) Buy 100–200 shares and sell $305 calls (covered call) to harvest 3.44% yieldboost, cap position at 2% NAV. Use IV trigger: enter when IV ≥ realized +2 pts (today true), exit/close when IV compresses to ≤30% or after a >7% adverse move; roll monthly on weakness.

Contrarian angles: Consensus underestimates optionality from AI software bookings — if IBM reports two consecutive quarters of accelerating software ARR growth, upside through $340+ would make covered calls expensive to continue and punish heavy put‑sellers. Conversely, the market may be underpricing assignment risk: high open interest at $295/$305 concentrates gamma and could amplify moves around catalysts (earnings, large contract announcements). Historical parallel: IBM’s multi‑year re‑rating cycles show step changes after clear cloud/recurring revenue inflection; be prepared to flip from income to directional within 1–3 quarters if fundamentals reaccelerate.

Key Decisions for Investors

• Establish a cash‑secured short put position: sell Feb‑2026 IBM $295 puts (collect ~$9.65) sizing 1–3% of portfolio only if comfortable owning IBM at $285.35; set hard close/roll rule if IBM falls below $270 or IV spikes >40%.
• If already long IBM, deploy covered calls: buy up to 100–200 shares and sell Feb‑2026 $305 calls to capture ~3.44% yield boost; cap total IBM exposure to 2% NAV and buy a protective $270 put if net position >2% NAV.
• Use IV spread as entry/exit: only initiate option income trades when implied vol ≥ realized vol +2 percentage points (currently true); exit or reduce exposure when IV ≤30% or if stock moves >7% against position within 30 days.
• Prepare a directional flip: if IBM reports two consecutive quarters of >5% YoY software/recurring revenue acceleration or announces material AI contract wins, close covered calls and redeploy proceeds to a 2–4% long position targeting $340 within 12 months.
• Avoid naked short exposure and limit aggregate assignment risk: maximum collective notional of cash‑secured puts + covered‑call underlying ≤5% NAV; monitor upcoming earnings and Fed decisions as 7–30 day catalysts to tighten stops.